{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:04:46Z","timestamp":1794330286192,"version":"4.9.0"},"reference-count":27,"publisher":"American Society for Clinical Investigation","issue":"2","license":[{"start":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T00:00:00Z","timestamp":1672444800000},"content-version":"vor","delay-in-days":347,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,18]]},"DOI":"10.1172\/jci156025","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T19:00:57Z","timestamp":1642446057000},"source":"Crossref","is-referenced-by-count":10,"title":["Using autoantibody signatures to define cancer risk in dermatomyositis"],"prefix":"10.1172","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1127-7879","authenticated-orcid":false,"given":"Jessica L.","family":"Turnier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4006-8945","authenticated-orcid":false,"given":"J. Michelle","family":"Kahlenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12451"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.068502"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1469-8"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab166"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2020.05.006"},{"issue":"2","key":"B6","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150201","article-title":"Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence","volume":"132","author":"Fiorentino","year":"2022","journal-title":"J Clin Invest"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0142-8"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/art.40893"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3245"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032414-112205"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041367"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/art.38863"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/art.37985"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.4.1317"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M805383200"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9900","article-title":"TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activation","volume":"6","author":"Ferri","year":"2015","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00979","article-title":"The roles of TIF1\u03b3 in cancer","volume":"9","author":"Yu","year":"2019","journal-title":"Front Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.05.037"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14579"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key357"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e31829d08f9"},{"issue":"3","key":"B22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","article-title":"Clinical associations of autoantibodies to a p155\/140 kDa doublet protein in juvenile dermatomyositis","volume":"47","author":"Gunawardena","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2017.12.053"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-014-0464-1"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/ar4198"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu259"},{"issue":"11","key":"B27","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/art.38093","article-title":"Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1gamma","volume":"65","author":"Fiorentino","year":"2013","journal-title":"Arthritis Rheum"}],"container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jci.org\/articles\/view\/156025\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T17:43:31Z","timestamp":1691084611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jci.org\/articles\/view\/156025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1,18]]},"published-print":{"date-parts":[[2022,1,18]]}},"alternative-id":["10.1172\/JCI156025"],"URL":"https:\/\/doi.org\/10.1172\/jci156025","relation":{},"ISSN":["1558-8238"],"issn-type":[{"value":"1558-8238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,18]]},"article-number":"e156025"}}